Previous studies revealed that that adiponectin presents anti-proliferative properties in prostate cancer cells and inhibits dihydrotestosterone-activated cell proliferation, IL-6, and IGF-I [61,62,63]. Here, ADIPOQ is linked to Familial prostate cancer.